Australian University Rankings Guide

BioDrugs: clinical immunotherapeutics biopharmaceuticals and gene therapy (ERA Journal)

BioDrugs: clinical immunotherapeutics biopharmaceuticals and gene therapy is an ERA accredited research journal used as part of the evaluation of the ERA research rankings.

BioDrugs: clinical immunotherapeutics biopharmaceuticals and gene therapy issns are issn1: 1172-7039 issn2: 1173-8804.

The field covered by BioDrugs: clinical immunotherapeutics biopharmaceuticals and gene therapy as part of the evaluation of Australian university research excellence is:

Pharmacology and Pharmaceutical Sciences Research Rankings (Sub-Field)

Other ERA-accredited journals supporting the evaluation of the Pharmacology and Pharmaceutical Sciences field include:

- Alimentary Pharmacology and Therapeutics
- Antibiotiki i Khimioterapiya
- Chemical and Pharmaceutical Bulletin
- Drug Metabolism Letters
- Drug Metabolism and Pharmacokinetics
- European Journal of Drug Metabolism and Pharmacokinetics
- Experimental and Clinical Psychopharmacology
- Immunotherapy
- Iranian Journal of Pharmacology and Therapeutics
- Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences
- Journal of Neuroimmune Pharmacology
- Journal of Pharmaceutical and Biomedical Analysis
- Medicinal Chemistry Research
- Regulatory Toxicology and Pharmacology
- Toxicon


ERA Research Rankings Submenu


- ERA 2018 Outcomes Research Rankings List

- ERA 2018 Research Rankings Analysis

- ERA 2018 Individual University Outcomes List

- ERA List of Research Fields Rankings

- ERA Journal Rankings 2018 List



Latest News and Updates:


- Top 10 Best Australian Universities

- Gender Balance Male-Female Ratio

- ERA 2018 Outcomes Research Rankings List

- University Bachelor Degree Completion Rates

- QS Employability Rankings Australian Universities

- ARWU World Rankings of Australian Universities

- Group of Eight (go8) World Rankings

Share This Page

  • Share on Facebook1
  • Share on Twitter2
  • Share on Linkedin3
  • Share on Reddit4